ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2012

Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.

Steven J Edwards et al.PubMed ↗Publisher ↗

No numbers read from the abstract.